Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 109
- +2 vs. Q1 2024
- Portfolio value
- $3.89B
- +$14.9M (+0.4%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Portage Fintech Acquisitn CoG7185D114 | *W EXP 07/08/202 | 126,666 | $3.55K | <0.1% | +126,666 | New | – |
| DLOdLocal Ltd | CLASS A COM | 10,482 | $84.8K | <0.1% | −19,518−65.1% | Reduced | History |
| DELLDell Technologies Inc. | Stock | 1,000 | $137.9K | <0.1% | +1,000 | New | History |
| CRBUCaribou Biosciences, Inc. | COM | 105,347 | $172.8K | <0.1% | 00.0% | Unchanged | History |
| KRSAKorsana Biosciences, Inc. | Stock | 117,643 | $270.6K | <0.1% | −21,312−15.3% | Reduced | History |
| RELYRemitly Global, Inc. | COM | 25,000 | $303.0K | <0.1% | +25,000 | New | History |
| TSLATesla, Inc. | Stock | 2,000 | $395.8K | <0.1% | 00.0% | Unchanged | History |
| INTAIntapp, Inc. | COM | 13,000 | $476.7K | <0.1% | −16,500−55.9% | Reduced | History |
| ADBEAdobe Inc. | Stock | 900 | $500.0K | <0.1% | −2,200−71.0% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 1,100 | $554.6K | <0.1% | +1,100 | New | History |
| CCCCCC Intelligent Solutions Holdings Inc. | COM | 50,000 | $555.5K | <0.1% | +50,000 | New | History |
| CFLTConfluent, Inc. | CLASS A COM | 19,000 | $561.1K | <0.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 755,375 | $615.6K | <0.1% | 00.0% | Unchanged | – |
| SNOWSnowflake Inc. | Stock | 5,051 | $682.3K | <0.1% | −1,449−22.3% | Reduced | History |
| PEGAPegasystems Inc | COM | 11,500 | $696.1K | <0.1% | 00.0% | Unchanged | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 110,532 | $720.7K | <0.1% | 00.0% | Unchanged | History |
| INTCIntel Corp | Stock | 25,000 | $774.3K | <0.1% | +25,000 | New | History |
| PYPLPayPal Holdings, Inc. | Stock | 15,000 | $870.5K | <0.1% | +5,000+50.0% | Added | History |
| FROGJFrog Ltd | Stock | 25,000 | $938.8K | <0.1% | +25,000 | New | History |
| BZKanzhun Ltd | SPONSORED ADS | 50,000 | $940.5K | <0.1% | +50,000 | New | History |
| EDUNew Oriental Education & Technology Group Inc. | SPON ADR | 12,500 | $971.6K | <0.1% | −2,500−16.7% | Reduced | History |
| MDBMongoDB, Inc. | CL A | 4,021 | $1.01M | <0.1% | +2,021+101.1% | Added | History |
| KRONKronos Bio, Inc. | COM | 842,954 | $1.05M | <0.1% | 00.0% | Unchanged | History |
| RBRKRubrik, Inc. | Stock | 35,000 | $1.07M | <0.1% | +35,000 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 91,426 | $1.18M | <0.1% | −223,070−70.9% | Reduced | History |
| MGXMetagenomi Therapeutics, Inc. | COM | 300,000 | $1.22M | <0.1% | 00.0% | Unchanged | History |
| GOOGLAlphabet Inc. | Stock | 7,000 | $1.28M | <0.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 809,600 | $1.34M | <0.1% | +809,600 | New | History |
| QCOMQualcomm Inc | Stock | 7,500 | $1.49M | <0.1% | +7,500 | New | History |
| KYTXKyverna Therapeutics, Inc. | COM | 200,000 | $1.50M | <0.1% | 00.0% | Unchanged | History |
| PANWPalo Alto Networks Inc | Stock | 4,500 | $1.53M | <0.1% | +1,500+50.0% | Added | History |
| PEPGPepGen Inc. | COM | 113,317 | $1.81M | <0.1% | −86,683−43.3% | Reduced | History |
| GRTSGritstone bio, Inc. | COM | 3,030,952 | $1.87M | <0.1% | +2,000,000+194.0% | Added | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $1.92M | <0.1% | 00.0% | Unchanged | History |
| NOWServiceNow, Inc. | Stock | 2,500 | $1.97M | 0.1% | +2,500 | New | History |
| PCORProcore Technologies, Inc. | COM | 32,300 | $2.14M | 0.1% | +22,800+240.0% | Added | History |
| CBIOCrescent Biopharma, Inc. | COM | 8,589,064 | $2.42M | 0.1% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 724,771 | $2.48M | 0.1% | 00.0% | Unchanged | History |
| KVUEKenvue Inc. | Stock | 137,000 | $2.49M | 0.1% | +137,000 | New | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,013,015 | $2.74M | 0.1% | −500,000−33.0% | Reduced | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,323,530 | $2.74M | 0.1% | 00.0% | Unchanged | History |
| RGNXREGENXBIO Inc. | COM | 250,000 | $2.92M | 0.1% | 00.0% | Unchanged | History |
| BEKEKE Holdings Inc. | SPONSORED ADS | 225,000 | $3.18M | 0.1% | −50,000−18.2% | Reduced | History |
| ADCTADC Therapeutics SA | SHS | 1,018,461 | $3.22M | 0.1% | +1,018,461 | New | History |
| HOOKHOOKIPA Pharma Inc. | COM | 5,666,410 | $3.35M | 0.1% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 1,032,500 | $3.39M | 0.1% | +672,189+186.6% | Added | History |
| AMZNAmazon Com Inc | Stock | 19,250 | $3.72M | 0.1% | +7,250+60.4% | Added | History |
| ANROAlto Neuroscience, Inc. | COM SHS | 350,000 | $3.74M | 0.1% | 00.0% | Unchanged | History |
| DDOGDatadog, Inc. | CL A COM | 28,925 | $3.75M | 0.1% | +19,325+201.3% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 720,720 | $4.14M | 0.1% | 00.0% | Unchanged | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 26,000 | $4.52M | 0.1% | −6,000−18.8% | Reduced | History |
| APLTApplied Therapeutics, Inc. | COM | 1,009,500 | $4.71M | 0.1% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 6,597,167 | $4.77M | 0.1% | 00.0% | Unchanged | History |
| DTDynatrace, Inc. | Stock | 109,000 | $4.88M | 0.1% | +73,000+202.8% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,046,517 | $4.88M | 0.1% | 00.0% | Unchanged | History |
| VVisa Inc. | Stock | 19,000 | $4.99M | 0.1% | +16,500+660.0% | Added | History |
| MSFTMicrosoft Corp | Stock | 11,300 | $5.05M | 0.1% | +8,800+352.0% | Added | History |
| NVDANVIDIA Corp | Stock | 43,000 | $5.31M | 0.1% | +24,000+126.3% | AddedConverted for a 10-for-1 split | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 45,500 | $6.05M | 0.2% | −11,000−19.5% | Reduced | History |
| SESea Ltd | SPONSORD ADS | 97,500 | $6.96M | 0.2% | −140,000−58.9% | Reduced | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 1,007,875 | $7.27M | 0.2% | +1,007,875 | New | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,828,691 | $7.31M | 0.2% | +17,500+1.0% | Added | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $7.98M | 0.2% | 00.0% | Unchanged | History |
| GBIOGeneration Bio Co. | COM | 2,830,591 | $7.98M | 0.2% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,011,500 | $8.11M | 0.2% | +1,011,500 | New | History |
| RAPPRapport Therapeutics, Inc. | COM | 350,000 | $8.14M | 0.2% | +350,000 | New | History |
| RNACCartesian Therapeutics, Inc. | COM NEW | 304,554 | $8.23M | 0.2% | +304,554 | New | History |
| JANXJanux Therapeutics, Inc. | COM | 203,000 | $8.50M | 0.2% | +153,000+306.0% | Added | History |
| SLRNACELYRIN, Inc. | COM | 2,020,888 | $8.91M | 0.2% | −384,255−16.0% | Reduced | History |
| LXEOLexeo Therapeutics, Inc. | COM | 603,435 | $9.68M | 0.2% | −198,281−24.7% | Reduced | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 4,354,214 | $9.75M | 0.3% | +666,666+18.1% | Added | History |
| BHVNBiohaven Ltd. | COM | 306,703 | $10.6M | 0.3% | +306,703 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 275,000 | $11.3M | 0.3% | +97,068+54.6% | Added | History |
| DNLIDenali Therapeutics Inc. | COM | 502,899 | $11.7M | 0.3% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 13,308,968 | $12.0M | 0.3% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 2,505,013 | $12.9M | 0.3% | 00.0% | Unchanged | History |
| AGENAgenus Inc | COM NEW | 775,000 | $13.0M | 0.3% | −6,562−0.8% | ReducedConverted for a 1-for-20 split | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 101,100 | $13.8M | 0.4% | +101,100 | New | History |
| KRROKorro Bio, Inc. | COM | 413,072 | $14.0M | 0.4% | −6,154−1.5% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM NEW | 2,500,000 | $14.2M | 0.4% | 00.0% | Unchanged | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 811,718 | $14.6M | 0.4% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 381,554 | $14.9M | 0.4% | +128,167+50.6% | Added | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 800,000 | $15.4M | 0.4% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,057,949 | $18.5M | 0.5% | +1,057,949 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,112,500 | $19.1M | 0.5% | +700,000+49.6% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 1,001,360 | $20.7M | 0.5% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 2,519,841 | $21.6M | 0.6% | +325,000+14.8% | Added | History |
| ERASErasca, Inc. | COM | 9,630,810 | $22.7M | 0.6% | +4,909,616+104.0% | Added | History |
| WVEWave Life Sciences, Inc. | SHS | 4,566,251 | $22.8M | 0.6% | +514,851+12.7% | Added | History |
| IGMSIGM Biosciences, Inc. | COM | 3,330,422 | $22.9M | 0.6% | +250,000+8.1% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 655,555 | $26.8M | 0.7% | +655,555 | New | – |
| CYTKCytokinetics Inc | COM NEW | 494,421 | $26.8M | 0.7% | −12,163−2.4% | Reduced | History |
| NMRANeumora Therapeutics, Inc. | COM | 2,824,052 | $27.8M | 0.7% | −100,000−3.4% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 915,974 | $33.1M | 0.9% | +409,955+81.0% | Added | History |
| KURAKura Oncology, Inc. | COM | 1,819,884 | $37.5M | 1.0% | −100,000−5.2% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 1,015,776 | $39.4M | 1.0% | −302,873−23.0% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 303,369 | $43.3M | 1.1% | −101,413−25.1% | Reduced | History |
| MRUSMerus N.V. | COM | 760,355 | $45.0M | 1.2% | +305,274+67.1% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,066,064 | $47.7M | 1.2% | −324,413−23.3% | Reduced | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 1,313,026 | $49.5M | 1.3% | −102,322−7.2% | Reduced | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2024 (20)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 110,507 | $29.5M | 0.8% | History |
| VKTXViking Therapeutics, Inc. | COM | 253,863 | $20.8M | 0.5% | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 405,784 | $16.1M | 0.4% | History |
| ATXSAstria Therapeutics, Inc. | COM | 884,214 | $12.4M | 0.3% | History |
| FOLDAmicus Therapeutics, Inc. | COM | 1,011,776 | $11.9M | 0.3% | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 253,000 | $10.6M | 0.3% | History |
| APGEApogee Therapeutics, Inc. | COM | 152,500 | $10.1M | 0.3% | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 151,780 | $6.51M | 0.2% | History |
| AXSMAxsome Therapeutics, Inc. | COM | 76,837 | $6.13M | 0.2% | History |
| RNACCartesian Therapeutics, Inc. | COM | 9,136,635 | $5.94M | 0.2% | History |
| GERNGeron Corp | COM | 1,281,194 | $4.23M | 0.1% | History |
| STOKStoke Therapeutics, Inc. | COM | 300,000 | $4.05M | 0.1% | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $3.30M | 0.1% | History |
| ADAGAdagene Inc. | ADS | 1,020,000 | $2.86M | 0.1% | History |
| VORVor Biopharma Inc. | COM | 1,000,000 | $2.37M | 0.1% | History |
| AAPLApple Inc. | Stock | 10,000 | $1.71M | <0.1% | History |
| AMDAdvanced Micro Devices Inc | Stock | 4,500 | $812.2K | <0.1% | History |
| CWANClearwater Analytics Holdings, Inc. | CL A | 25,000 | $442.3K | <0.1% | History |
| HIPOHippo Holdings Inc. | COM NEW | 24,000 | $438.5K | <0.1% | History |
| INKTMiNK Therapeutics, Inc. | COM | 1,916 | $1.74K | <0.1% | History |